Cover Image
市場調查報告書

United Biomedical, Inc.的產品平台分析

United Biomedical, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251731
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
United Biomedical, Inc.的產品平台分析 United Biomedical, Inc. - Product Pipeline Review - 2015
出版日期: 2015年10月14日 內容資訊: 英文 28 Pages
簡介

United Biomedical, Inc.是總公司在美國的生物製藥企業,進行著慢性疾病及感染疾病的免疫療法藥和疫苗的藥物研發、開發及商品化。該公司的產品有過敏用疫苗、HIV疫苗、家畜用疫苗、生技仿製藥等,還有利用肽設計的技術,商品化一連串的血液篩檢診斷用醫藥品、合成肽疫苗。

本報告提供United Biomedical, Inc. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標靶、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

United Biomedical, Inc. 的基本資料

  • United Biomedical, Inc. 概要
  • 主要資訊
  • 企業資料

United Biomedical, Inc. :R&D概要

  • 主要的治療範圍

United Biomedical, Inc. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

United Biomedical, Inc. :開發中產品概況

  • 在臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

United Biomedical, Inc. :藥物簡介

  • UB-311
  • UB-421
  • HIV (gp120) vaccine
  • HIV vaccine
  • Synthetic Peptide for Undisclosed Indication
  • TW-01003
  • Vaccine for Allergy

United Biomedical, Inc. :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

United Biomedical, Inc. :最近的開發平台資訊

United Biomedical, Inc. :開發休止的計劃

United Biomedical, Inc. :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07654CDB

Summary

Global Markets Direct's, 'United Biomedical, Inc. - Product Pipeline Review - 2015', provides an overview of the United Biomedical, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of United Biomedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of United Biomedical, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of United Biomedical, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the United Biomedical, Inc.'s pipeline products

Reasons to buy

  • Evaluate United Biomedical, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of United Biomedical, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the United Biomedical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of United Biomedical, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of United Biomedical, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of United Biomedical, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • United Biomedical, Inc. Snapshot
    • United Biomedical, Inc. Overview
    • Key Information
    • Key Facts
  • United Biomedical, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • United Biomedical, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • United Biomedical, Inc. - Pipeline Products Glance
    • United Biomedical, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • United Biomedical, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • United Biomedical, Inc. - Drug Profiles
    • UB-421
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV vaccine 1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TW-01003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • United Biomedical, Inc. - Pipeline Analysis
    • United Biomedical, Inc. - Pipeline Products by Target
    • United Biomedical, Inc. - Pipeline Products by Route of Administration
    • United Biomedical, Inc. - Pipeline Products by Molecule Type
    • United Biomedical, Inc. - Pipeline Products by Mechanism of Action
  • United Biomedical, Inc. - Recent Pipeline Updates
  • United Biomedical, Inc. - Dormant Projects
  • United Biomedical, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • United Biomedical, Inc., Key Information
  • United Biomedical, Inc., Key Facts
  • United Biomedical, Inc. - Pipeline by Indication, 2015
  • United Biomedical, Inc. - Pipeline by Stage of Development, 2015
  • United Biomedical, Inc. - Monotherapy Products in Pipeline, 2015
  • United Biomedical, Inc. - Partnered Products in Pipeline, 2015
  • United Biomedical, Inc. - Partnered Products/ Combination Treatment Modalities, 2015
  • United Biomedical, Inc. - Phase II, 2015
  • United Biomedical, Inc. - Preclinical, 2015
  • United Biomedical, Inc. - Pipeline by Target, 2015
  • United Biomedical, Inc. - Pipeline by Route of Administration, 2015
  • United Biomedical, Inc. - Pipeline by Molecule Type, 2015
  • United Biomedical, Inc. - Pipeline Products by Mechanism of Action, 2015
  • United Biomedical, Inc. - Recent Pipeline Updates, 2015
  • United Biomedical, Inc. - Dormant Developmental Projects,2015
  • United Biomedical, Inc., Subsidiaries

List of Figures

  • United Biomedical, Inc. - Pipeline by Top 10 Indication, 2015
  • United Biomedical, Inc. - Pipeline by Stage of Development, 2015
  • United Biomedical, Inc. - Monotherapy Products in Pipeline, 2015
  • United Biomedical, Inc. - Pipeline by Top 10 Target, 2015
  • United Biomedical, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top